Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Verstoorde balans tussen hersennetwerken bij mensen met MS met cognitieve problemen
feb 2017 | Multipele Sclerose